IMC’s CertiScan® medication adherence software includes the pioneering Morisky scale for medication adherence. Working with the scale in CertiScan is easier, more powerful, and more real-time than other methods. CertiScan automatically delivers questions to patients, handles data management, conducts statistical analysis, and produces actionable insights
Many professionals consider the Morisky Medication Adherence Scales (MMAS) to be the gold standard of medical adherence questionnaires. The 4-item MMAS 4, and the 8-item MMAS 8 help you assess patient adherence and perform tailored interventions.
CertiScan®is the leading medication adherence solution for smart medication adherence packaging, and it also supports the MMAS. Together, MMAS and CertiScan are a powerful patient adherence solution. The MMAS is a psychological instrument that complements CertiScan’s smart pack and smart dose analytics. And CertiScan is an adherence software platform ideal for delivering and managing survey data.
With the digital MMAS you get high quality data in a cost effective and scalable way. Proactively ensure that your patient population is taking medications as prescribed. Dig into the root causes of medication non adherence, such as side effects, forgetfulness, and other barriers. And only pay for what you use.
Drug development can use the MMAS as part of a clinical trial CRO solution that improves patient outcomes. Public health can use MMAS to track the effectiveness of medication adherence measures. Patient care providers can use the MMAS to guide medication therapy management and chronic disease management.
Inappropriate medication use is widespread in clinical research. This can harm individual participant outcomes, jeopardize trial outcomes, and cause hidden errors that are only discovered post market or after publishing (such as a poorly titrated dosage or undiscovered side effect).
Our solutions make it easy to detect and treat these harmful issues. Many protective features are automatic, such as mobile reminders, misuse alerts, targeted coaching.Shorter trials that reach their endpoints more quickly can gain weeks or months of additional patent protection. This can amount to substantial additional revenue.
Our solutions help studies reach last dose, last participant sooner.Clinical trials are becoming increasingly complex and expensive. Certain activities in a protocol seem straightforward on paper, but in practice can translate into dozens of hours of site work.
Use our solutions to help eliminate needless overhead and streamline processes.New, technology-first strategies are transforming clinical trials. DCTs, participant diversity initiatives, and AI tools are changing from “nice-to-haves” into “must-haves”.
Our solutions are modern tools for modern trials that can help researchers and other stakeholders gain and maintain an advantage.
Background: Non-adherence to prescription medications is exhibited by approximately 50% of patients and is…
Read More
PRESS RELEASE May 6, 2024 – New York, NY — Information Mediary Corp (IMC)…
Read More